Global Bioenergies finalized the acquisition of Syngip B.V. at the close of its extraordinary shareholders’ meeting last Thursday. Established in the Netherlands since 2014, Syngip develops a process to convert gaseous carbon sources into light olefins. Its process is based on a proprietary micro-organism capable of metabolising carbon dioxide (CO2) and carbon monoxide (CO) found in a wide range of low-cost and abundant streams, such as the industrial waste emissions of steel mills.
Global Bioenergies expands in the Netherlands. The French biotech company led by Marc Delcourt signed a contribution agreement with the shareholders of Syngip B.V. to transfer all Syngip shares to Global Bioenergies S.A. The transaction’s completion remains subject to the fulfilment of several suspensive conditions including approval by the shareholders of Global Bioenergies.
IL BIOECONOMISTA 